drugset / Trial / NCT04148573
Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In summary, this small-scale study is designed to demonstrate that the NFX88 is safe and well tolerated, as well as preliminary evidence of improvement in the score of VAS, PD-Q, and PGIC scales.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2022-05-20
- Completion
- 2022-07-20
Publications
- Results Avila-Martin G, Galan-Arriero I, Ferrer-Donato A, Busquets X, Gomez-Soriano J, Escriba PV, Taylor J. Oral 2-hydroxyoleic acid inhibits reflex hypersensitivity and open-field-induced anxiety after spared nerve injury. Eur J Pain. 2015 Jan;19(1):111-22. doi: 10.1002/ejp.528. Epub 2014 May 13.
- Results Avila-Martin G, Mata-Roig M, Galan-Arriero I, Taylor JS, Busquets X, Escriba PV. Treatment with albumin-hydroxyoleic acid complex restores sensorimotor function in rats with spinal cord injury: Efficacy and gene expression regulation. PLoS One. 2017 Dec 15;12(12):e0189151. doi: 10.1371/journal.pone.0189151. eCollection 2017.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NFX88 | Unknown | 1.05 g | Oral |
| Comparator | NFX88 | Unknown | 2.1 g | Oral |
| Comparator | NFX88 | Unknown | 4.2 g | Oral |